Previous Article | Next Article ![]()
Infect. Immun., 12 1997, 5171-5175, Vol 65, No. 12
SF Little, BE Ivins, PF Fellows and AM Friedlander
The protective effects of polyclonal antisera produced by injecting guinea
pigs with protective antigen (PA), the chemical anthrax vaccine AVA, or
Sterne spore vaccine, as well as those of toxin-neutralizing monoclonal
antibodies (MAbs) produced against PA, lethal factor, and edema factor,
were examined in animals infected with Bacillus anthracis spores. Only the
anti-PA polyclonal serum significantly protected the guinea pigs from
death, with 67% of infected animals surviving. Although none of the MAbs
was protective, one PA MAb caused a significant delay in time to death. Our
findings demonstrate that antibodies produced against only PA can provide
passive protection against anthrax infection in guinea pigs.
Copyright © 1997, American Society for Microbiology
Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs
Bacteriology Division, United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland 21702-5011, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|